Request Deal Involvement

Taisho Pharma to acquire UPSA from Bristol-Myers Squibb for $1.6bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Jefferies & Company

financial advisors

Jefferies & Company

Kirkland & Ellis

legal advisors

Kirkland & Ellis

Deutsche Bank

financial advisors

Deutsche Bank

Freshfields Bruckhaus Deringer

legal advisors

Freshfields Bruckhaus Deringer

Baker McKenzie

legal advisors

Baker McKenzie

Morrison Foerster

legal advisors

Morrison Foerster

or

Principals

BRISTOL MYERS SQUIBB COMPANY

vendor

BRISTOL MYERS SQUIBB COMPANY

TAISHO PHARMACEUTICAL

bidder

TAISHO PHARMACEUTICAL

UNION DE PHARMACOLOGIE SCIENTIFIQUE APPLIQUEE

target

UNION DE PHARMACOLOGIE SCIENTIFIQUE APPLIQUEE

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Taisho Pharma to acquire UPSA from Bristol-Myers Squibb for $1.6bn.